Active Pharmaceutical Ingredient (API)
Abiraterone Acetate
CYP17A1 Inhibitor (Prostate Cancer)
Used for metastatic castration-resistant prostate cancer. It inhibits the enzyme $\text{CYP}17\text{A}1$, which is required for androgen biosynthesis in the testes, adrenal glands, and tumor tissue.
Technical Profile
- Reference Code
- ABI627
- CAS Number
- 154229-18-2
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Abiraterone Acetate as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Glistroma 250 H | Alkem Laboratories Ltd | Tablet (250 mg) | ₹18,480.00 | View Details |
| Alkeprost 500 H | Alkem Laboratories Ltd | Tablet (500 mg) | ₹12,500.00 | View Details |
| Abirunat 250 H | Natco Pharma Ltd | Tablet (250 mg) | ₹24,500.00 | View Details |
| Abiralaur 250 H | Laurus Labs Limited | Tablet (250 mg) | ₹23,500.00 | View Details |